Although we do not know the exact time when MAP2 starts to drop-down during prion infection, our data here indicate that the expression of MAP2 in neurons is more vulnerable during the progression of prion diseases, which may reflect that both the biological function of MAP2 in neurons and the cluster of MAP2 positive neurons are affected. The gene discussed is MAP2; the disease is prion disease.